Bariatric Surgery: Clinical Trials

2 trials for Bariatric Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2
Phase 21Unknown 1

Follow Bariatric Surgery: new trials by email Literature Review of Bariatric Surgery trials Research Report on Bariatric Surgery

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naldebain for Pain Control After Bariatric Surgery
Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic
Phase 2 / Phase 3UnknownE-DA Hospital602021-06-242021-12-28
Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
biliopancreatic diversion, antidiabetics - Type 2 Diabetes Mellitus, Bariatric Surgery
Phase 3UnknownIRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy402009-07-012010-01-12

Narrower conditions

Chronic Pain (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Pain, Postoperative (1)

Broader conditions

Nutritional and Metabolic Diseases (2)  ·  Body Weight (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nutrition Disorders (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms (1)

Interventions

Biliopancreatic Diversion (1)  ·  Hypoglycemic Agents (1)  ·  sebacoyl dinalbuphine ester (1)

Sponsors

E-DA Hospital (1)  ·  IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy (1)

Countries

Italy (1)  ·  Taiwan (1)

Top investigators

Chen-Fuh Lam, MD, PhD (1)